$214.55
1.88% day before yesterday
NYSE, Apr 25, 10:10 pm CET
ISIN
US9553061055
Symbol
WST

West Pharmaceutical Services, Inc. Stock price

$214.55
-11.25 4.98% 1M
-93.37 30.32% 6M
-113.01 34.50% YTD
-153.63 41.73% 1Y
-134.40 38.52% 3Y
+16.71 8.45% 5Y
+158.62 283.60% 10Y
NYSE, Closing price Fri, Apr 25 2025
+3.96 1.88%
ISIN
US9553061055
Symbol
WST
Sector

Key metrics

Market capitalization $15.51b
Enterprise Value $15.41b
P/E (TTM) P/E ratio 33.69
EV/FCF (TTM) EV/FCF 50.22
EV/Sales (TTM) EV/Sales 5.32
P/S ratio (TTM) P/S ratio 5.36
P/B ratio (TTM) P/B ratio 5.78
Dividend yield 0.38%
Last dividend (FY24) $0.82
Revenue growth (TTM) Revenue growth -1.14%
Revenue (TTM) Revenue $2.90b
EBIT (operating result TTM) EBIT $597.60m
Free Cash Flow (TTM) Free Cash Flow $306.90m
Cash position $404.20m
EPS (TTM) EPS $6.37
P/E forward 35.43
P/S forward 5.24
EV/Sales forward 5.21
Short interest 2.59%
Show more

Is West Pharmaceutical Services, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,790 stocks worldwide.

West Pharmaceutical Services, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

12x Buy
75%
4x Hold
25%

Analyst Opinions

16 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

Buy
75%
Hold
25%

Financial data from West Pharmaceutical Services, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,896 2,896
1% 1%
100%
- Direct Costs 1,892 1,892
3% 3%
65%
1,004 1,004
8% 8%
35%
- Selling and Administrative Expenses 178 178
13% 13%
6%
- Research and Development Expense 68 68
2% 2%
2%
757 757
7% 7%
26%
- Depreciation and Amortization 160 160
13% 13%
6%
EBIT (Operating Income) EBIT 598 598
12% 12%
21%
Net Profit 467 467
18% 18%
16%

In millions USD.

Don't miss a Thing! We will send you all news about West Pharmaceutical Services, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

West Pharmaceutical Services, Inc. Stock News

Neutral
Seeking Alpha
3 days ago
West Pharmaceutical Services, Inc. (NYSE:WST ) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ET Company Participants John Sweeney - Vice President of Investor Relations Eric Green - Chairman, President and Chief Executive Officer Bernard Birkett - Senior Vice President and Chief Financial Officer Conference Call Participants Paul Knight - KeyBanc Larry Solow - CJS Securities Justin Bo...
Positive
Reuters
3 days ago
West Pharmaceutical Services raised its annual profit forecast on Thursday, anticipating a boost from a weaker dollar to shield it from a potential hit from U.S. President Donald Trump's tariffs.
Neutral
PRNewsWire
3 days ago
Bernard J. Birkett Announces Intention to Retire from West, Company Initiates Search for a Successor Shane Campbell Appointed Senior Vice President, Chief Proprietary Segment Officer EXTON, Pa. , April 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced executive leadership changes a...
More West Pharmaceutical Services, Inc. News

Company Profile

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Head office United States
CEO Eric Green
Employees 10,600
Founded 1923
Website www.westpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today